Project Outline: FMEA for Safe COVID‑19 Vaccination Administration in the Medical Group

To ensure safe, reliable, and error‑free administration of COVID‑19 vaccines across the Medical Group, a Failure Modes and Effects Analysis (FMEA) was conducted to proactively identify risks associated with incorrect vaccine administration. This initiative aligned with systemwide quality and safety goals and supported the organization’s commitment to zero harm. I provided strategic oversight and partnered with multidisciplinary teams to design and implement a sustainable, high‑reliability solution.

FMEA Process

I convened a cross‑functional group including:

• Nursing and clinical operations

• Quality & Safety

• Service Line leadership

• Marketing & Communications

• Supply Chain

• Clinical Education

• Pharmacy

• Frontline caregivers from high‑volume vaccination sites

The team documented each step of the vaccination process, from scheduling to post‑vaccination observation, identifying points where incorrect vaccine selection or administration could occur.

Project Goals

• Prevent incorrect COVID‑19 vaccine administration across all Medical Group locations.

• Standardize workflows to reduce variability and cognitive burden on clinical staff.

• Strengthen visual cues and human‑factor design elements to support safe vaccine delivery.

• Engage cross‑functional partners to ensure operational, clinical, and patient‑facing alignment.

1. Assemble a Multidisciplinary Team

2. Map the Current Vaccination Workflow

3. Identify Failure Modes and Risk Priority Numbers

Potential failure modes included:

• Selecting the wrong vaccine vial

• Mislabeling syringes

• Administering a vaccine different from what the patient consented to

• Confusion between vaccine types due to similar packaging or labeling

Each failure mode was scored for severity, occurrence, and detectability to determine

4. Prioritize High‑Risk Failure Modes

The highest‑risk issues centered on visual similarity between vaccine types and the lack of ability to barcode scan the vaccine due to it being Emergency use.

Solution Development

Color‑Coded Labeling System

To address the highest‑risk failure modes, you led the development of a color‑coded system that aligned the color of the vaccine vial with:

• Color‑matched labels applied to prepared syringes

• Color‑coded patient stickers stating “I got my COVID‑19 vaccine”

This created a closed‑loop visual verification process:

• The vaccinator could confirm the correct vaccine by matching the syringe label color to the patient’s sticker color.

• Staff could quickly identify discrepancies before administration.

• The system reduced reliance on memory and minimized cognitive load.

Cross‑Functional Collaboration

• Marketing partnered to design patient‑friendly, brand‑consistent stickers and signage.

• Service Line leadership ensured operational alignment across all vaccination sites.

• Clinical Education integrated the new process into training and competency materials.

• Quality & Safety monitored implementation fidelity and tracked outcomes.

Outcomes & Summary

Zero Incorrect COVID‑19 Vaccine Administration Events

Following implementation, the Medical Group reported zero vaccine errors related to incorrect COVID‑19 vaccine administration. This outcome directly supported the organization’s culture of zero harm and demonstrated the effectiveness of human‑factor‑informed design.

Summary

This FMEA‑driven initiative exemplifies my leadership in proactive risk mitigation, cross‑functional collaboration, and innovative problem‑solving. By integrating human‑centered design with operational strategy, I delivered a scalable solution that eliminated a high‑risk safety concern and reinforced systemwide reliability.